How many institutional investors hold AAPG?

2 tracked institutional investors disclosed a position in AAPG (ASCENTAGE PHARMA GROUP INTL) in their most recent 13F filing.

Who is the largest institutional holder of AAPG?

Steve Cohen, Point72 Asset Management, holds the largest disclosed position in AAPG, valued at $438,890.

Where does this AAPG ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

AAPG — ASCENTAGE PHARMA GROUP INTL

Name: ASCENTAGE PHARMA GROUP INTL (AAPG) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About ASCENTAGE PHARMA GROUP INTL (AAPG)

ASCENTAGE PHARMA GROUP INTL (AAPG) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $438,890. Across recent filings, tracked investors recorded 3 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in AAPG

100

/100

Strong Institutional Accumulation

Added / Increased3

Reduced0

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track AAPG

/100

Undiscovered

2investors

Only 2 tracked investors report this position.

UndiscoveredCrowded

151015+

AAPG Ownership Composition

How ASCENTAGE PHARMA GROUP INTL is held across tracked investor types, based on reported 13F positions.

Dominant Type

Hedge Funds

60% of tracked value

Institutions

tracked investors

Total Reported

$638.3K

combined 13F value

Hedge Funds60.0%
Other40.0%

Hedge Funds(1)

60.0%

Other(1)

40.0%

Tracked investors reporting AAPG

Investor	Firm	Shares	Market value	% of portfolio	As of
Steve Cohen	Point72 Asset Management	16.1K	$383.3K	0.00%	Mar 31, 2026
Ken Griffin	Citadel Advisors	9.7K	$255K	0.00%	Dec 31, 2025

Steve CohenMar 31, 2026
Point72 Asset Management
Shares
16.1K
Value
$383.3K
% Portfolio
0.00%
Ken GriffinDec 31, 2025
Citadel Advisors
Shares
9.7K
Value
$255K
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Steve Cohen	New	—	$438.9K	Feb 17, 2026
Steve Cohen	New	—	$383.3K	May 15, 2026
Ken Griffin	New	—	$383.1K	Nov 14, 2025

Steve Cohen
New
$438.9KFeb 17, 2026
Steve Cohen
New
$383.3KMay 15, 2026
Ken Griffin
New
$383.1KNov 14, 2025

Frequently asked questions

How many institutional investors hold AAPG?: 2 tracked institutional investors disclosed a position in AAPG (ASCENTAGE PHARMA GROUP INTL) in their most recent 13F filing.
Who is the largest institutional holder of AAPG?: Steve Cohen, Point72 Asset Management, holds the largest disclosed position in AAPG, valued at $438,890.
Did institutional ownership of AAPG increase or decrease?: Across recent 13F filings, tracked investors recorded 3 new positions, 0 increased, 0 reduced, and 0 fully exited AAPG.
Where does this AAPG ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.